Contact
About us
Management team
Board of Directors
Advisory Board
About GBS
Innovation
Our approach
Our pipeline
Clinical trials
Publications
News
Press releases
Media contact
Investors
Our Investors
Financial reports
Investor contact
Join us
Home
Elements
Blog Layouts
OUR NEWS
Masonry Post Grid
All
Press Release
OUR NEWS
Latest Posts
17 September 2024
MinervaX and Wacker Biotech Announce Manufacturing Collaboration for Prophylactic Vaccine Targeting Group B Streptococcus
11 October 2023
MinervaX Raises EUR 54M in Upsized Financing to Advance the Development of its Maternal Vaccine Against Group B Streptococcus
27 June 2023
MinervaX Announces Completion of Enrolment in Phase 1 Clinical Vaccine Trial as it Addresses the Global Burden of Group B Streptococcus in Older Adults